These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11843826)

  • 1. Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum.
    Goudeau C; Loyevsky M; Kassim OO; Gordeuk VR; Nick H
    Br J Haematol; 2001 Dec; 115(4):918-23. PubMed ID: 11843826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.
    Hershko C; Konijn AM; Nick HP; Breuer W; Cabantchik ZI; Link G
    Blood; 2001 Feb; 97(4):1115-22. PubMed ID: 11159545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin.
    Hasinoff BB; Patel D; Wu X
    Free Radic Biol Med; 2003 Dec; 35(11):1469-79. PubMed ID: 14642395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zinc-desferrioxamine on Plasmodium falciparum in culture.
    Chevion M; Chuang L; Golenser J
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1902-5. PubMed ID: 7486946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin.
    Sonnet P; Mullié C
    Exp Parasitol; 2011 May; 128(1):26-31. PubMed ID: 21295029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.
    Loyevsky M; Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
    J Clin Invest; 1993 Jan; 91(1):218-24. PubMed ID: 8423220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites.
    Loyevsky M; Cabantchik ZI
    Mol Pharmacol; 1994 Mar; 45(3):446-52. PubMed ID: 8145731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
    Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
    J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
    Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
    Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.
    Ford SJ; Obeidy P; Lovejoy DB; Bedford M; Nichols L; Chadwick C; Tucker O; Lui GY; Kalinowski DS; Jansson PJ; Iqbal TH; Alderson D; Richardson DR; Tselepis C
    Br J Pharmacol; 2013 Mar; 168(6):1316-28. PubMed ID: 23126308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
    Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
    Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chelation of thallium by combining deferasirox and desferrioxamine in rats.
    Saljooghi AS; Babaie M; Mendi FD; Zahmati M; Saljooghi ZS
    Toxicol Ind Health; 2016 Jan; 32(1):83-8. PubMed ID: 24021432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
    van Zyl RL; Havlik I; Monteagudo FS
    J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
    Lytton SD; Cabantchik ZI; Libman J; Shanzer A
    Mol Pharmacol; 1991 Oct; 40(4):584-90. PubMed ID: 1921988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
    Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific ultrastructural effects of desferrioxamine on Plasmodium falciparum in vitro.
    Atkinson CT; Bayne MT; Gordeuk VR; Brittenham GM; Aikawa M
    Am J Trop Med Hyg; 1991 Nov; 45(5):593-601. PubMed ID: 1951869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
    Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
    Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and in vitro antimalarial activity of an acylhydrazone library.
    Melnyk P; Leroux V; Sergheraert C; Grellier P
    Bioorg Med Chem Lett; 2006 Jan; 16(1):31-5. PubMed ID: 16263280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of novel iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and green tea extract on growth of Plasmodium falciparum.
    Thipubon P; Uthaipibull C; Kamchonwongpaisan S; Tipsuwan W; Srichairatanakool S
    Malar J; 2015 Sep; 14():382. PubMed ID: 26424148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.